Ads
related to: light bleeding when wiping after urinating treatment- Dosing & Administration
See dosage and administration info
for an available PH1 treatment.
- About PH1
Discover an FDA-approved treatment
for patients with PH1.
- Patient Brochure
Help your patients
understand their condition.
- Fill Out the Start Form
Fill out the Start Form to get
access to therapy.
- Efficacy & Safety
Read the efficacy & safety profile
of this treatment option for PH1.
- Clinical Data
Review clinical trial data for an
available PH1 treatment.
- Dosing & Administration
Search results
Results From The WOW.Com Content Network
Urethrorrhagia refers to urethral bleeding in the absence of urine associated with dysuria and blood spots on underwear after voiding. This condition, which often occurs in prepubertal boys at intervals several months apart over a period of many years, has a benign self-limited course.
Micturition syncope or post-micturition syncope is the name given to the human phenomenon of fainting shortly after or during urination.The underlying cause is not fully understood, but it may be a result of vasovagal response, postural hypotension, or a combination thereof.
This includes avoiding use of vaginal deodorant sprays and proper wiping after urination and bowel movements. Sexual intercourse should be avoided at least 7 days after completion of treatment (and until symptoms resolves, if present). [11] Past and current sexual partners should also be assessed and treated. [5]
Hematuria can be classified according to visibility, anatomical origin, and timing of blood during urination. [1] [6]In terms of visibility, hematuria can be visible to the naked eye (termed "gross hematuria") and may appear red or brown (sometimes referred to as tea-colored), or it can be microscopic (i.e. not visible but detected with a microscope or laboratory test).
Hemorrhagic cystitis or haemorrhagic cystitis is an inflammation of the bladder defined by lower urinary tract symptoms that include dysuria, hematuria, and hemorrhage.The disease can occur as a complication of cyclophosphamide, ifosfamide and radiation therapy.
A post-void residual urine greater than 50 ml is a significant amount of urine and increases the potential for recurring urinary tract infections. [citation needed] In adults older than 60 years, 50-100 ml of residual urine may remain after each voiding because of the decreased contractility of the detrusor muscle. [7]